LOS ANGELES, Dec. 9, 2019 /PRNewswire/ — ImaginAb Inc., a clinical-stage immuno-oncology imaging company, announces it has initiated its Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at Penn Medicine in Philadelphia, PA. Penn Medicine is one of the world’s leading academic medical centers. 89Zr-Df-IAB22M2C is a first in class imaging agent that visualizes the […]
Enzyre, which is developing breakthrough ambulant diagnostic technology for coagulation testing, today announced that it has entered into a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda) to develop a diagnostic device that will enable hemophilia patients to determine their coagulation status at home. Hemophilia is a rare genetic disorder that affects approximately 400,000 […]
IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience clinical drug development, today announces that it is scheduled to attend and present scientific posters at the 2019 Clinical Trials on Alzheimer’s Disease (CTAD) Congress held from 4th-7th December 2019 in San Diego, California, USA. CTAD Congress 2019 4th – 7th December […]
PARIS and NEW YORK, Dec. 2, 2019 /PRNewswire/ — Owkin, which is developing Federated Learning and AI technologies to advance medical research, announces it is teaming up with technology company NVIDIA and King’s College London (KCL) to deliver Federated Learning in the healthcare and life sciences sector. The King’s College London Medical Imaging and AI Centre for Value Based Healthcare (AI4VBH) is […]
LANGENFELD, Germany, Nov. 28, 2019 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), announces expansion of its operations in Southern Europe with the launch of Neuraxpharm Portugal. Based in Lisbon, Neuraxpharm Portugal will be part of the Company’s Southern European Region that comprises Italy, Spain and now Portugal. Neuraxpharm aims to build its position as a […]
